Chronic FXR activation with OCA is a potential strategy for activating IL-10/IL-10R signalling, reversing cardiac regulatory T cell dysfunction, and improving inflammasome-mediated NASH-related cardiac dysfunction. This evidence concerns the gene IL10RA and metabolic dysfunction-associated steatohepatitis.